Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Pharmacoepidemiology and Drug Safety|May 3, 2014
Risk of malignancies in patients with inflammatory bowel disease treated with thiopurines or anti-TNF alpha antibodiesFlorian Beigel, Anni Steinborn, Fabian Schnitzler, et al.
Journal of Hepatology|June 21, 2005
A multicenter assessment of liver toxicity by MRI and biopsy in IBD patients on 6-thioguanineJulia Seiderer, Christoph J Zech, Walter Reinisch, et al.
Plos One|February 1, 2013
IRGM variants and susceptibility to inflammatory bowel disease in the German populationJürgen Glas, Julia Seiderer, Stephanie Bues, et al.
Inflammatory Bowel Diseases|December 20, 2007
Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBDJulia Seiderer, Ira Elben, Julia Diegelmann, et al.
Clinical Immunology (Orlando, Fla.)|February 6, 2008
Genotype-phenotype analysis of the CXCL16 p.Ala181Val polymorphism in inflammatory bowel diseaseJulia Seiderer, Julia Dambacher, Dorothea Leistner, et al.
Inflammatory Bowel Diseases|January 9, 2007
Macrophage migration inhibitory factor (MIF) -173G/C promoter polymorphism influences upper gastrointestinal tract involvement and disease activity in patients with Crohn's diseaseJulia Dambacher, Tanja Staudinger, Julia Seiderer, et al.
Plos One|March 30, 2012
PTPN2 gene variants are associated with susceptibility to both Crohn's disease and ulcerative colitis supporting a common genetic disease backgroundJürgen Glas, Johanna Wagner, Julia Seiderer, et al.
Plos One|April 6, 2012
Analysis of IL12B gene variants in inflammatory bowel diseaseJürgen Glas, Julia Seiderer, Johanna Wagner, et al.
Inflammatory Bowel Diseases|August 11, 2011
Pregnane X receptor (PXR/NR1I2) gene haplotypes modulate susceptibility to inflammatory bowel diseaseJürgen Glas, Julia Seiderer, Daniel Fischer, et al.
Plos One|January 10, 2013
PTGER4 expression-modulating polymorphisms in the 5p13.1 region predispose to Crohn's disease and affect NF-κB and XBP1 binding sitesJürgen Glas, Julia Seiderer, Darina Czamara, et al.
Pageof 5